Shots:
- J&J temporarily pause the use of the COVID-19 vaccine in the US, following recommended of the CDC and FDA. The review data involves six reported cases of a rare and severe type of blood clot in the US after receiving the J&J vaccine
- The pause is due to the unusual clotting in 6 women aged 18-48 with symptoms occurring in 6-13 days after vaccination, in combination with reduced platelet counts. Additionally, J&J delay the rollout of the vaccine in the EU and pause vaccinations in all COVID-19 vaccine clinical trials
- The similar blood clot problem seen in AstraZeneca’s COVID 19 vaccine, as reported by several EU countries which prompted curbs to its use
Source 1 , Source 2 to read full press release/ article | Ref: J&J | Image: Reuters
The post J&J Pauses Dosing of COVID-19 Vaccine Due to Blood Clotting first appeared on PharmaShots.
